Literature DB >> 14661928

Determination of the dermal penetration of esterom components using microdialysis sampling.

Sarah McDonald1, Craig Lunte.   

Abstract

PURPOSE: Esterom Solution, an investigational pharmaceutical product, is derived from the esterification of benzoylmethylecgonine (cocaine) in 1.2 propanediol. The resulting solution contains a mixture of components. Esterom Solution is intended to be a topical analgesic to relieve pain and increase the range of motion in patients suffering from acute inflammation of the shoulder or back. Although the components of Esterom are known, the components that are responsible for analgesia have only recently been identified. The purpose of this research is to evaluate which components have the ability to penetrate the skin, how much actually penetrates, and if and/or how each component is metabolized and distributed locally.
METHODS: Linear microdialysis probes were implanted into rat dermis. The individual components present in the Esterom Solution were applied separately to the dermis directly over a probe. Dermal dialysis samples were collected to evaluate the dermal penetration of each compound following topical application.
RESULTS: Following a 10 mg/50 microL application. 1.8 +/- 0.6 mM benzoic acid was detected at the plateau after approximately 220 min. Following hydroxypropyl benzoic acid application, complete hydrolysis to benzoic acid was observed with a plateau concentration of 137 +/- 19 microM (150 min plateau). When applied separately, hydroxypropyl benzoylecgonine and ecgonine penetrate the skin with plateau concentrations of 32 +/- 9 microM (15 h plateau) and 36 +/- 5 microM (150 min plateau) respectively. Benzoylecgonine, the hydrolytic product of HP-BE, was also detected with a plateau concentration of 3.9 +/- 0.1 microM (16 h plateau) Applied topically, ecgonidine, methylecgonidine, benzoylecgonine, and hydroxypropyl ecgonidine were not detected.
CONCLUSIONS: Of the components with analgesic activity, the only compound that penetrates the skin is hydroxypropyl benzoylecgonine. Dermal microdialysis was shown to be an effective technique to monitor the skin penetration of topically applied compounds.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14661928      PMCID: PMC2519827          DOI: 10.1023/b:pham.0000003381.10208.8c

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

Review 1.  Microdialysis for the evaluation of penetration through the human skin barrier - a promising tool for future research?

Authors:  E Schnetz; M Fartasch
Journal:  Eur J Pharm Sci       Date:  2001-01       Impact factor: 4.384

Review 2.  Microdialysis in clinical drug delivery studies.

Authors:  M Müller
Journal:  Adv Drug Deliv Rev       Date:  2000-12-15       Impact factor: 15.470

3.  On the dermal absorption of cocaine.

Authors:  R C Baselt; J Y Chang; D M Yoshikawa
Journal:  J Anal Toxicol       Date:  1990 Nov-Dec       Impact factor: 3.367

4.  Simplified quantitation of urinary benzoylecgonine in cocaine addiction research and for related pharmacotherapeutic trials.

Authors:  J E Peters; J Z Chou; A Ho; K Reid; L Borg; M J Kreek
Journal:  Addiction       Date:  1996-11       Impact factor: 6.526

5.  Dermal microdialysis sampling in vivo.

Authors:  J M Ault; C M Riley; N M Meltzer; C E Lunte
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

6.  Urinary excretion of ecgonine methyl ester, a major metabolite of cocaine in humans.

Authors:  J Ambre; M Fischman; T I Ruo
Journal:  J Anal Toxicol       Date:  1984 Jan-Feb       Impact factor: 3.367

7.  Propylene glycol as a vehicle for percutaneous absorption of therapeutic agents.

Authors:  D N Bailey
Journal:  J Anal Toxicol       Date:  1992 Mar-Apr       Impact factor: 3.367

Review 8.  Use of tetracaine, epinephrine, and cocaine as a topical anesthetic in the emergency department.

Authors:  S A Grant; R S Hoffman
Journal:  Ann Emerg Med       Date:  1992-08       Impact factor: 5.721

9.  Cocaine and benzoylecgonine constrict cerebral arteries by different mechanisms.

Authors:  J A Madden; R J Konkol; P A Keller; T A Alvarez
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

  9 in total
  2 in total

1.  Concentration profiling in rat tissue by high-resolution magic-angle spinning NMR spectroscopy: investigation of a model drug.

Authors:  Laura H Lucas; Sarah F Wilson; Craig E Lunte; Cynthia K Larive
Journal:  Anal Chem       Date:  2005-05-01       Impact factor: 6.986

2.  AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives.

Authors:  Chandra S Chaurasia; Markus Müller; Edward D Bashaw; Eva Benfeldt; Jan Bolinder; Ross Bullock; Peter M Bungay; Elizabeth C M DeLange; Hartmut Derendorf; William F Elmquist; Margareta Hammarlund-Udenaes; Christian Joukhadar; Dean L Kellogg; Craig E Lunte; Carl Henrik Nordstrom; Hans Rollema; Ronald J Sawchuk; Belinda W Y Cheung; Vinod P Shah; Lars Stahle; Urban Ungerstedt; Devin F Welty; Helen Yeo
Journal:  Pharm Res       Date:  2007-03-27       Impact factor: 4.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.